Journal
ONCOTARGET
Volume 8, Issue 62, Pages 105615-105629Publisher
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.22350
Keywords
indirubin; influenza virus; virus susceptibility; MAVS; STING
Categories
Funding
- Natural Science Foundation of China [81573675, 81473115, 81622050, 81402981, 81673709]
- Science and Technology Program of Guangzhou [2013J4501037]
- Youth Top-notch Talent Support Program of Guangdong Province [2014TQ01R229, 2016TQ03R586]
- TCM Modernization Program of Hainan Province [2015ZY01]
Ask authors/readers for more resources
Isatis indigotica has a long history in treating virus infection and related symptoms in China. Nevertheless, its antivirus evidence in animal studies is not satisfactory, which might be due to the lack of appropriate animal model. Previously, we had utilized restraint stress to establish mouse H1N1 susceptibility model which was helpful in evaluating the anti-virus effect of medicines targeting host factors, such as type I interferon production. In this study, this model was employed to investigate the effect and mechanism of indirubin, a natural bisindole alkaloid from Isatis indigotica, on influenza A virus susceptibility. In the in vitro study, the stress hormone corticosterone was used to simulate restraint stress. Our results demonstrated that indirubin decreased the susceptibility to influenza virus with lowered mortality and alleviated lung damage in restraint-stressed mice model. Moreover, indirubin promoted the expression of interferon-beta and interferon inducible transmembrane 3. In addition, indirubin maintained the morphology and function of mitochondria following influenza A virus infection. Further study revealed that indirubin promoted interferon-beta production through promoting mitochondrial antiviral signaling pathway. Our study indicated that indirubin could be a candidate for the therapy of influenza.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available